Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder
Completed
- Conditions
- Autism Spectrum Disorder
- Registration Number
- NCT03819439
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Brief Summary
Analyze, describe, and understand how the human gut microbiome (i.e. bacteriome and mycobiome) and Autism Spectrum Disorder (ASD) are related.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
- Volunteers > 2 years of age
- Able to list all medical conditions and medications when applicable.
- Have already donated a stool sample to BIOHM™.
Exclusion Criteria
- Volunteers < 2 years of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characterize the microbiome [bacteria and fungal community] 10 years Identifying relative abundance of individual bacterial and fungal members.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What microbial metabolites in the gut-brain axis correlate with ASD severity in NCT03819439 registry data?
How do fungal (mycobiome) and bacterial (bacteriome) interactions in the gut differ between ASD and neurotypical volunteers?
Which 16S rRNA sequencing biomarkers predict response to microbiome-targeted therapies in ASD populations?
What adverse events are associated with gut microbiome modulation in ASD clinical trials beyond NCT03819439?
How do prebiotic/probiotic interventions compare to fecal microbiota transplantation (FMT) in ASD therapeutic strategies?
Trial Locations
- Locations (1)
University Hospitals Cleveland Medical Center
🇺🇸Cleveland, Ohio, United States
University Hospitals Cleveland Medical Center🇺🇸Cleveland, Ohio, United States